Literature DB >> 23615270

Topical drug formulations for prolonged corneal anesthesia.

Liqiang Wang1, Sahadev A Shankarappa, Rong Tong, Joseph B Ciolino, Jonathan H Tsui, Homer H Chiang, Daniel S Kohane.   

Abstract

PURPOSE: Ocular local anesthetics currently used in routine clinical practice for corneal anesthesia are short acting and their ability to delay corneal healing makes them unsuitable for long-term use. In this study, we examined the effect of the site 1 sodium channel blocker tetrodotoxin (TTX) on the duration of corneal anesthesia, applied with either proparacaine (PPC) or the chemical permeation enhancer octyl-trimethyl ammonium bromide (OTAB). The effect of test solutions on corneal healing was also studied.
METHODS: Solutions of TTX, PPC, and OTAB, singly or in combination, were applied topically to the rat cornea. The blink response, an indirect measure of corneal sensitivity, was recorded using a Cochet-Bonnet esthesiometer, and the duration of corneal anesthesia was calculated. The effect of test compounds on the rate of corneal epithelialization was studied in vivo after corneal debridement.
RESULTS: Combination of TTX and PPC resulted in corneal anesthesia that was 8 to 10 times longer in duration than that from either drug administered alone, whereas OTAB did not prolong anesthesia. The rate of corneal healing was moderately delayed after coadministration of TTX and PPC.
CONCLUSIONS: Coadministration of TTX and PPC significantly prolonged corneal anesthesia, but in view of delayed corneal reepithelialization, caution is suggested in the use of the drug combination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23615270      PMCID: PMC3679302          DOI: 10.1097/ICO.0b013e31828cbfe6

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  27 in total

1.  Design principles of chemical penetration enhancers for transdermal drug delivery.

Authors:  Pankaj Karande; Amit Jain; Kaitlin Ergun; Vincent Kispersky; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

2.  Experimental study of tetrodotoxin, a long-acting topical anesthetic.

Authors:  D M Schwartz; H L Fields; K G Duncan; J L Duncan; M R Jones
Journal:  Am J Ophthalmol       Date:  1998-04       Impact factor: 5.258

3.  Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity.

Authors:  Robert F Padera; Julie Y Tse; Evangelia Bellas; Daniel S Kohane
Journal:  Muscle Nerve       Date:  2006-12       Impact factor: 3.217

4.  Molecular determinants of state-dependent block of Na+ channels by local anesthetics.

Authors:  D S Ragsdale; J C McPhee; T Scheuer; W A Catterall
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

5.  Factors influencing patient choice of refractive surgery or contact lenses and choice of centre.

Authors:  Navneet Gupta; Shehzad A Naroo
Journal:  Cont Lens Anterior Eye       Date:  2005-12-07       Impact factor: 3.077

6.  Bevacizumab application delays epithelial healing in rabbit cornea.

Authors:  Tae-im Kim; Jae Lim Chung; Jin Pyo Hong; Kyung Min; Kyoung Yul Seo; Eung Kweon Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-20       Impact factor: 4.799

7.  Tetrodotoxin: anesthetic activity in the de-epithelialized cornea.

Authors:  D M Schwartz; K G Duncan; H L Fields; M R Jones
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-10       Impact factor: 3.117

8.  Effect of chemical permeation enhancers on nerve blockade.

Authors:  Emmanuel J Simons; Evangelia Bellas; Michael W Lawlor; Daniel S Kohane
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

9.  A comparison of proparacaine and tetracaine eye anesthetics.

Authors:  J M Bartfield; T J Holmes; N Raccio-Robak
Journal:  Acad Emerg Med       Date:  1994 Jul-Aug       Impact factor: 3.451

10.  A re-examination of tetrodotoxin for prolonged duration local anesthesia.

Authors:  D S Kohane; J Yieh; N T Lu; R Langer; G R Strichartz; C B Berde
Journal:  Anesthesiology       Date:  1998-07       Impact factor: 7.892

View more
  12 in total

1.  Ciprofloxacin-lidocaine-based hydrogel: development, characterization, and in vivo evaluation in a second-degree burn model.

Authors:  María Florencia Sanchez; Susana Andrea Breda; Elio Andrés Soria; Luis Ignacio Tártara; Rubén Hilario Manzo; María Eugenia Olivera
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Corneal Anesthesia With Site 1 Sodium Channel Blockers and Dexmedetomidine.

Authors:  James Brian McAlvin; Changyou Zhan; Jenny C Dohlman; Paraskevi E Kolovou; Borja Salvador-Culla; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

3.  Deep topical anesthesia with ropivacaine-soaked sponge for phacoemulsification.

Authors:  Gianluca Scuderi; Luca Scuderi; Silvia Calafiore; Vito Fenicia; Solmaz Abdolrahimzadeh
Journal:  Int Ophthalmol       Date:  2019-05-31       Impact factor: 2.031

Review 4.  Getting Drugs Across Biological Barriers.

Authors:  Rong Yang; Tuo Wei; Hannah Goldberg; Weiping Wang; Kathleen Cullion; Daniel S Kohane
Journal:  Adv Mater       Date:  2017-07-28       Impact factor: 30.849

5.  Long-acting liposomal corneal anesthetics.

Authors:  Changyou Zhan; Claudia M Santamaria; Weiping Wang; J Brian McAlvin; Daniel S Kohane
Journal:  Biomaterials       Date:  2018-08-09       Impact factor: 12.479

6.  Transtympanic Delivery of Local Anesthetics for Pain in Acute Otitis Media.

Authors:  Rong Yang; Riitta Saarinen; Obiajulu S Okonkwo; Yi Hao; Manisha Mehta; Daniel S Kohane
Journal:  Mol Pharm       Date:  2019-03-06       Impact factor: 4.939

7.  Effects of topical application of tramadol with/without dexmedetomidine and proparacaine on corneal sensitivity in rats.

Authors:  Cristina A Lelescu; Daria A Dumitras; Sonia Iurian; Francesco Staffieri; Cosmin Muresan
Journal:  Int Ophthalmol       Date:  2020-10-23       Impact factor: 2.031

8.  Prolonged Duration Topical Corneal Anesthesia With the Cationic Lidocaine Derivative QX-314.

Authors:  Alan G Woodruff; Claudia M Santamaria; Manisha Mehta; Grant L Pemberton; Kathleen Cullion; Daniel S Kohane
Journal:  Transl Vis Sci Technol       Date:  2019-10-17       Impact factor: 3.283

Review 9.  Addressing the Issue of Tetrodotoxin Targeting.

Authors:  Daria I Melnikova; Yuri S Khotimchenko; Timur Yu Magarlamov
Journal:  Mar Drugs       Date:  2018-09-26       Impact factor: 5.118

Review 10.  Topical anesthesia.

Authors:  Mritunjay Kumar; Rajiv Chawla; Manish Goyal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.